NEFL and Alzheimer disease: While not fully explaining disease development, many protein studies focus on biomarkers for diagnosis and prognosis of patients, such as α-synuclein (92), neurofilament light chain protein (NfL) (93), or even amyloid beta and phosphorylated tau in addition to other proteins commonly associated to AD (94).